AirDuo Digihaler
Generic name:fluticasone propionate and salmeterol
Dosage form: inhalation powder, metered
Drug class:Bronchodilator combinations
Medically reviewed by Drugs.com. Last updated on Apr 1, 2022.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for AirDuo Digihaler
AirDuo® Digihaler® is indicated for the treatment of asthma in adult and pediatric patients aged 12 years and older. AirDuo Digihaler should be used for patients not adequately controlled on a long term asthma control medication such as an inhaled corticosteroid or whose disease warrants initiation of treatment with both an inhaled corticosteroid and long acting beta2-adrenergic agonist (LABA).
Limitations of Use:
AirDuo Digihaler is not indicated for the relief of acute bronchospasm.
AirDuo Digihaler Dosage and Administration
2.1 Administration Instructions
- AirDuo Digihaler is for oral inhalation and does not require priming.
- Do not use AirDuo Digihaler with a spacer or volume holding chamber.
- Do not use more than two times every 24 hours. More frequent administration or a greater number of daily inhalations (more than one inhalation twice daily) is not recommended as some patients are more likely to experience adverse reactions with higher salmeterol dosages.
- Avoid the concomitant use of other long acting beta2-adrenergic agonist (LABAs) [see Warnings and Precautions (5.3, 5.11)].
If asthma symptoms arise in the period between doses, an inhaled, short-acting beta2-agonist should be taken for immediate relief.
2.2 Recommended Dosage
Administer 1 inhalation of Air...
